Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TesoRx Pharma LLC
DescriptionOral pro-liposomal formulation of unmodified testosterone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation
PartnerAspen Pharmacare Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today